Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients

Table 4 Variations of lymphocytes

Variables	Period	Supplemented	Control	P
Total lymphocytes No. cells × 109/cm3	Baseline	1.62 ± 0.41	1.73 ± 0.38	NS
	D 1	1.12 ± 0.39	1.55 ± 0.33	NS
	D 8	1.55 ± 0.33	1.18 ± 0.35	< 0.05
CD3 (%)	Baseline	72.2 ± 11.1	69.0 ± 9.8	NS
	D 1	60.1 ± 8.8	57.7 ± 10.3	NS
	D 8	76.4 ± 14.5	60.3 ± 9.3	< 0.05
CD4 (%)	Baseline	45.0 ± 8.5	42.5 ± 9.2	NS
	D 1	38.2 ± 9.4	37.7 ± 9.0	NS
	D 8	57.5 ± 7.8	40.0 ± 8.6	< 0.05
CD8 (%)	Baseline	23.3 ± 7.4	24.5 ± 7.7	NS
	D 1	22.7 ± 8.0	22.2 ± 8.0	NS
	D 8	19.6 ± 6.6	23.1 ± 5.9	< 0.05
CD4/CD8	Baseline	1.9 ± 0.8	1.7 ± 0.7	NS
	D 1	1.7 ± 1.2	1.7 ± 0.9	NS
	D 8	2.9 ± 1.4	1.7 ± 0.8	< 0.01
NK cells (%)	Baseline	17.7 ± 7.1	18.3 ± 6.9	NS
	D 1	11.1 ± 8.2	10.2 ± 7.2	NS
	D 8	16.6 ± 5.4	11.1 ± 4.3	< 0.05